Wenxia Zhao Selected Research

Wenxia Zhao Research Topics

Disease

13	Neoplasms (Cancer) 02/2024 - 06/2011
5	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 12/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2023 - 12/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022 - 01/2022
2	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2021
2	Fatigue 01/2022 - 04/2018
2	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 05/2015
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2012
2	Pre-Eclampsia (Preeclampsia) 01/2021 - 01/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 06/2011
1	Osteoarthritis 03/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024
1	Hypertrophy 10/2023
1	Cardiomegaly (Heart Hypertrophy) 10/2023
1	Schistosomiasis (Bilharziasis) 09/2023
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 03/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Carcinogenesis 01/2023
1	Ileus 11/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2022
1	Dyspepsia (Indigestion) 01/2022
1	Edema (Dropsy) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Colitis 07/2021
1	Ulcerative Colitis 07/2021
1	Hepatitis 01/2021
1	Autoimmune Hepatitis 01/2021
1	Heart Failure 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Myocardial Infarction 01/2020
1	Stroke (Strokes) 01/2020

Drug/Important Bio-Agent (IBA)

7	MicroRNAs (MicroRNA)IBA 09/2023 - 01/2012
4	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2021
3	CateninsIBA 01/2024 - 03/2022
2	SodiumIBA 03/2023 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 03/2023 - 01/2020
2	Immune Checkpoint InhibitorsIBA 11/2022 - 09/2022
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 04/2018 - 05/2015
2	Furazolidone (Furoxone)FDA Link 12/2013 - 07/2013
2	MitogensIBA 12/2013 - 07/2013
2	p38 Mitogen-Activated Protein KinasesIBA 12/2013 - 07/2013
1	oxybenzone (Solbar)FDA Link 03/2024
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2024
1	UbiquitinIBA 02/2024
1	biliverdin reductaseIBA 01/2024
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 10/2023
1	icariinIBA 10/2023
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2023
1	ArtesunateIBA 09/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2023
1	CopperIBA 01/2023
1	Cell Adhesion MoleculesIBA 05/2022
1	Deubiquitinating EnzymesIBA 05/2022
1	Messenger RNA (mRNA)IBA 05/2022
1	Peptide Hydrolases (Proteases)FDA Link 05/2022
1	CaspasesIBA 03/2022
1	Transcription Factor CHOPIBA 03/2022
1	zhibitaiIBA 01/2022
1	wulingIBA 01/2022
1	TabletsIBA 01/2022
1	qiangganIBA 01/2022
1	Nonprescription Drugs (Patent Medicines)IBA 01/2022
1	Capsules (Microcapsules)IBA 01/2022
1	4-chlorophenyl methyl sulfide (CPMS)IBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	flavoneIBA 10/2021
1	scutellareinIBA 10/2021
1	qing-chang-hua-shi granulesIBA 07/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2021
1	Flavin Mononucleotide (FMN)IBA 01/2021
1	Concanavalin AIBA 01/2021
1	formononetinIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	G-protein-coupled receptor 34IBA 01/2021
1	CholesterolIBA 01/2020
1	ClathrinIBA 01/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020
1	Exenatide (Byetta)FDA Link 01/2020
1	Pioglitazone (Actos)FDA Link 01/2020
1	Rosiglitazone (Avandia)FDA Link 01/2020
1	LipidsIBA 01/2020
1	Liraglutide FDA Link 01/2020
1	CanagliflozinIBA 01/2020
1	empagliflozinIBA 01/2020
1	dulaglutideIBA 01/2020
1	rGLP-1 proteinIBA 01/2020
1	dapagliflozinIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	semaglutideIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	glimepiride (Amarel)FDA LinkGeneric 01/2020

Therapy/Procedure

10	Therapeutics 09/2023 - 01/2012
1	Drug Therapy (Chemotherapy) 03/2022
1	Radiotherapy 03/2022
1	Aftercare (After-Treatment) 01/2022
1	Acupuncture Points (Acupuncture Point) 01/2022